Graphical abstract template · Nanomaterial applications · Drug delivery
Targeted drug delivery with nanoparticles
A 3D-style graphical abstract of nanoparticle drug delivery: the anatomy of a multifunctional liposomal carrier (targeting ligands, PEG corona, bilayer, drug payloads, imaging agent), passive tumour targeting through the EPR effect, and active targeting with receptor-mediated endocytosis and triggered drug release.
Updated 1 cited paper193 editable layers
At a glance
- Category
- Nanomaterial applications
- Method
- Drug delivery
- Product
- Ligand-targeted, PEGylated nanocarriers (typically 50–200 nm)
- Figure
- 1800 × 1300 px (16:9), 193 editable layers
Step by step
- CirculationPEG corona limits protein adsorption and immune clearance
- Passive targetingExtravasation through leaky tumour vessels (EPR effect)
- Active targetingLigand–receptor binding, endocytosis, triggered release
Uses
- Nanomedicine papers and reviews
- Teaching passive and active targeting
Papers this template follows
- Peer et al., “Nanocarriers as an emerging platform for cancer therapy”, Nat. Nanotechnol. 2007. doi:10.1038/nnano.2007.387review
Overview after Peer et al., Nat. Nanotechnol. 2007 (doi:10.1038/nnano.2007.387). The carrier, vessels and cell are schematic, not to scale; sizes and pH values are typical literature ranges.
How templates are written and checked: editorial guidelines.
Questions
What does the “Targeted drug delivery with nanoparticles” template show?
A 3D-style graphical abstract of nanoparticle drug delivery: the anatomy of a multifunctional liposomal carrier (targeting ligands, PEG corona, bilayer, drug payloads, imaging agent), passive tumour targeting through the EPR effect, and active targeting with receptor-mediated endocytosis and triggered drug release.
What are the steps shown in “Targeted drug delivery with nanoparticles”?
1. Circulation: PEG corona limits protein adsorption and immune clearance. 2. Passive targeting: Extravasation through leaky tumour vessels (EPR effect). 3. Active targeting: Ligand–receptor binding, endocytosis, triggered release.
Which papers is “Targeted drug delivery with nanoparticles” based on?
Peer et al., “Nanocarriers as an emerging platform for cancer therapy”, Nat. Nanotechnol. 2007 (doi:10.1038/nnano.2007.387).
Can I edit the “Targeted drug delivery with nanoparticles” template?
Yes. Open it in the LabCanvas editor: all 193 layers are editable. Change the text, colours and layout, then export PNG, TIFF, SVG or PDF.
Do I need an account to use this template?
Not to view it here. To open and edit it, sign in to LabCanvas or create a free account (the free plan keeps one design of each kind). Downloading the figure is part of LabCanvas Pro (US$19 a month or US$199 a year).
